• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用商业酶纤维素酶KN生产人参皂苷F1。

Production of ginsenoside F1 using commercial enzyme Cellulase KN.

作者信息

Wang Yu, Choi Kang-Duk, Yu Hongshan, Jin Fengxie, Im Wan-Taek

机构信息

College of Biotechnology, Dalian Polytechnic University, Ganjingzi-qu, Dalian, PR China; Department of Biotechnology, Hankyong National University, Anseong, Korea.

Genomic Informatics Center, Graduate School of Future Convergence Technology, Hankyong National University, Anseong, Korea.

出版信息

J Ginseng Res. 2016 Apr;40(2):121-6. doi: 10.1016/j.jgr.2015.06.003. Epub 2015 Jun 19.

DOI:10.1016/j.jgr.2015.06.003
PMID:27158232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4845047/
Abstract

BACKGROUND

Ginsenoside F1, a pharmaceutical component of ginseng, is known to have antiaging, antioxidant, anticancer, and keratinocyte protective effects. However, the usage of ginsenoside F1 is restricted owing to the small amount found in Korean ginseng.

METHODS

To enhance the production of ginsenoside F1 as a 10 g unit with high specificity, yield, and purity, an enzymatic bioconversion method was developed to adopt the commercial enzyme Cellulase KN from Aspergillus niger with food grade, which has ginsenoside-transforming ability. The proposed optimum reaction conditions of Cellulase KN were pH 5.0 and 50°C.

RESULTS

Cellulase KN could effectively transform the ginsenosides Re and Rg1 into F1. A scaled-up biotransformation reaction was performed in a 10 L jar fermenter at pH 5.0 and 50°C for 48 h with protopanaxatriol-type ginsenoside mixture (at a concentration of 10 mg/mL) from ginseng roots. Finally, 13.0 g of F1 was produced from 50 g of protopanaxatriol-type ginsenoside mixture with 91.5 ± 1.1% chromatographic purity.

CONCLUSION

The results suggest that this enzymatic method could be exploited usefully for the preparation of ginsenoside F1 to be used in cosmetic, functional food, and pharmaceutical industries.

摘要

背景

人参皂苷F1是人参的一种药用成分,已知具有抗衰老、抗氧化、抗癌和保护角质形成细胞的作用。然而,由于在高丽参中含量较少,人参皂苷F1的应用受到限制。

方法

为了以高特异性、产率和纯度大量生产10克单位的人参皂苷F1,开发了一种酶促生物转化方法,采用食品级的黑曲霉商业酶纤维素酶KN,其具有人参皂苷转化能力。所提出的纤维素酶KN的最佳反应条件为pH 5.0和50°C。

结果

纤维素酶KN可有效地将人参皂苷Re和Rg1转化为人参皂苷F1。在10 L罐式发酵罐中,于pH 5.0和50°C下,用人参根中的原人参三醇型人参皂苷混合物(浓度为10 mg/mL)进行放大生物转化反应48小时。最后,从50克原人参三醇型人参皂苷混合物中生产出13.0克人参皂苷F1,色谱纯度为91.5±1.1%。

结论

结果表明,这种酶促方法可有效地用于制备人参皂苷F1,用于化妆品、功能性食品和制药行业。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/377d4666775f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/647cb9cc62f5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/b0da52076b87/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/85e391bffe61/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/af8ef85455ef/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/377d4666775f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/647cb9cc62f5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/b0da52076b87/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/85e391bffe61/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/af8ef85455ef/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564e/4845047/377d4666775f/gr5.jpg

相似文献

1
Production of ginsenoside F1 using commercial enzyme Cellulase KN.使用商业酶纤维素酶KN生产人参皂苷F1。
J Ginseng Res. 2016 Apr;40(2):121-6. doi: 10.1016/j.jgr.2015.06.003. Epub 2015 Jun 19.
2
Identification and characterization of a ginsenoside-transforming β-glucosidase from Pseudonocardia sp. Gsoil 1536 and its application for enhanced production of minor ginsenoside Rg2(S).从假诺卡氏菌属Gsoil 1536中鉴定和表征一种人参皂苷转化β-葡萄糖苷酶及其在提高次要人参皂苷Rg2(S)产量中的应用
PLoS One. 2014 Jun 9;9(6):e96914. doi: 10.1371/journal.pone.0096914. eCollection 2014.
3
Production of the Rare Ginsenoside Rh2-MIX (20()-Rh2, 20()-Rh2, Rk2, and Rh3) by Enzymatic Conversion Combined with Acid Treatment and Evaluation of Its Anti-Cancer Activity.通过酶促转化结合酸处理制备稀有皂苷Rh2混合物(20()-Rh2、20()-Rh2、Rk2和Rh3)及其抗癌活性评估。
J Microbiol Biotechnol. 2017 Jul 28;27(7):1233-1241. doi: 10.4014/jmb.1701.01077.
4
Comparative analysis of the expression level of recombinant ginsenoside-transforming β-glucosidase in GRAS hosts and mass production of the ginsenoside Rh2-Mix.GRAS宿主中重组人参皂苷转化β-葡萄糖苷酶表达水平的比较分析及人参皂苷Rh2-Mix的大规模生产。
PLoS One. 2017 Apr 19;12(4):e0176098. doi: 10.1371/journal.pone.0176098. eCollection 2017.
5
Mass production of the ginsenoside Rg3(S) through the combinative use of two glycoside hydrolases.通过两种糖苷水解酶的组合使用大规模生产人参皂苷 Rg3(S)。
Food Chem. 2013 Nov 15;141(2):1369-77. doi: 10.1016/j.foodchem.2013.04.012. Epub 2013 Apr 18.
6
High-density immobilization of a ginsenoside-transforming β-glucosidase for enhanced food-grade production of minor ginsenosides.高浓度固定化转化人参皂苷的β-葡萄糖苷酶,以增强食品级低人参皂苷的生产。
Appl Microbiol Biotechnol. 2019 Sep;103(17):7003-7015. doi: 10.1007/s00253-019-09951-4. Epub 2019 Jul 9.
7
Gram-Scale Production of Ginsenoside F1 Using a Recombinant Bacterial β-Glucosidase.使用重组细菌β-葡萄糖苷酶进行人参皂苷 F1 的规模化生产。
J Microbiol Biotechnol. 2017 Sep 28;27(9):1559-1565. doi: 10.4014/jmb.1703.03006.
8
Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848.利用黑曲霉 g.848 中的特殊型 I 型糖苷酶从西洋参 PPD 型人参皂苷制备次要人参皂苷 C-Mc、C-Y、F2 和 C-K。
J Ginseng Res. 2015 Jul;39(3):221-9. doi: 10.1016/j.jgr.2014.12.003. Epub 2014 Dec 31.
9
Synthesis of a Novel α-Glucosyl Ginsenoside F1 by Cyclodextrin Glucanotransferase and Its In Vitro Cosmetic Applications.新型 α-葡萄糖基人参皂苷 F1 的环糊精葡萄糖基转移酶合成及其体外化妆品应用。
Biomolecules. 2018 Nov 10;8(4):142. doi: 10.3390/biom8040142.
10
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 from protopanaxatriol-type ginseng saponin mixture.从原人参三醇型人参皂苷混合物中酶法制备人参皂苷Rg2、Rh1和F1。
Planta Med. 2003 Mar;69(3):285-6. doi: 10.1055/s-2003-38476.

引用本文的文献

1
Modulating flavanone compound for reducing the bitterness and improving dietary fiber, physicochemical properties, and anti-adipogenesis of green yuzu powder by enzymatic hydrolysis.用于通过酶水解降低青柚子粉的苦味并改善其膳食纤维、理化性质和抗脂肪生成作用的黄酮类化合物调节剂。
Food Chem X. 2024 Mar 27;22:101329. doi: 10.1016/j.fochx.2024.101329. eCollection 2024 Jun 30.
2
Rare ginsenosides: A unique perspective of ginseng research.稀有皂苷:人参研究的独特视角。
J Adv Res. 2024 Dec;66:303-328. doi: 10.1016/j.jare.2024.01.003. Epub 2024 Jan 7.
3
Regulation of transcriptome networks that mediate ginsenoside biosynthesis by essential ecological factors.

本文引用的文献

1
A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases.人参及人参皂苷对心血管疾病药用潜能的综述。
J Ginseng Res. 2014 Jul;38(3):161-6. doi: 10.1016/j.jgr.2014.03.001. Epub 2014 Apr 3.
2
Protective effect of Korean Red Ginseng extract against Helicobacter pylori-induced gastric inflammation in Mongolian gerbils.红参提取物对蒙古沙土鼠幽门螺杆菌诱导性胃炎症的保护作用。
J Ginseng Res. 2014 Jan;38(1):8-15. doi: 10.1016/j.jgr.2013.11.005. Epub 2013 Dec 8.
3
Identification and characterization of a Mucilaginibacter sp. strain QM49 β-glucosidase and its use in the production of the pharmaceutically active minor ginsenosides (S)-Rh1 and (S)-Rg2.
调控转录组网络,介导人参皂苷生物合成的基本生态因素。
PLoS One. 2023 Aug 17;18(8):e0290163. doi: 10.1371/journal.pone.0290163. eCollection 2023.
4
Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathways.人参皂苷F1通过调节Nrf2和AKT/Bcl-2信号通路减轻吡柔比星诱导的心脏毒性。
J Ginseng Res. 2023 Jan;47(1):106-116. doi: 10.1016/j.jgr.2022.06.002. Epub 2022 Jul 5.
5
Production of minor ginsenosides by combining Stereum hirsutum and cellulase.利用糙皮侧耳和纤维素酶生产低含量人参皂苷。
PLoS One. 2021 Aug 6;16(8):e0255899. doi: 10.1371/journal.pone.0255899. eCollection 2021.
6
Diversity of Ginsenoside Profiles Produced by Various Processing Technologies.不同加工工艺生产的人参皂苷成分多样性。
Molecules. 2020 Sep 24;25(19):4390. doi: 10.3390/molecules25194390.
7
Biocatalytic strategies for the production of ginsenosides using glycosidase: current state and perspectives.利用糖苷酶生产人参皂苷的生物催化策略:现状与展望。
Appl Microbiol Biotechnol. 2020 May;104(9):3807-3823. doi: 10.1007/s00253-020-10455-9. Epub 2020 Mar 3.
8
Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products.人参及红参在乳制品中的生物转化、健康益处及应用
Food Sci Biotechnol. 2017 Aug 17;26(5):1155-1168. doi: 10.1007/s10068-017-0159-2. eCollection 2017.
9
Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling.人参皂苷F1通过A20介导的NF-κB信号抑制改善内皮细胞炎症损伤并预防小鼠动脉粥样硬化。
Front Pharmacol. 2017 Dec 22;8:953. doi: 10.3389/fphar.2017.00953. eCollection 2017.
10
Comprehensive Profiling and Quantification of Ginsenosides in the Root, Stem, Leaf, and Berry of Panax ginseng by UPLC-QTOF/MS.采用 UPLC-QTOF/MS 技术全面分析和定量测定人参的根、茎、叶和果实中的人参皂苷。
Molecules. 2017 Dec 4;22(12):2147. doi: 10.3390/molecules22122147.
一株粘质沙雷氏菌 QM49 β-葡萄糖苷酶的鉴定与特性分析及其在(S)-Rh1 和(S)-Rg2 等具有药用活性的低含量人参皂苷生产中的应用。
Appl Environ Microbiol. 2013 Oct;79(19):5788-98. doi: 10.1128/AEM.01150-13. Epub 2013 Jun 28.
4
Ginseng in traditional herbal prescriptions.传统草药方剂中的人参。
J Ginseng Res. 2012 Jul;36(3):225-41. doi: 10.5142/jgr.2012.36.3.225.
5
Characterization of the ginsenoside-transforming recombinant β-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides.从美丽放线菌中鉴定人参皂苷转化重组β-葡萄糖苷酶及主要人参皂苷向次要人参皂苷的生物转化。
Appl Microbiol Biotechnol. 2013 Jan;97(2):649-59. doi: 10.1007/s00253-012-4324-5. Epub 2012 Aug 22.
6
Bioconversion of major ginsenosides Rg1 to minor ginsenoside F1 using novel recombinant ginsenoside hydrolyzing glycosidase cloned from Sanguibacter keddieii and enzyme characterization.新型来源于血杆菌属的人参皂苷水解糖苷酶的克隆及其酶学性质在人参皂苷 RG1 向 F1 的生物转化中的应用
J Biotechnol. 2012 Oct 31;161(3):294-301. doi: 10.1016/j.jbiotec.2012.06.021. Epub 2012 Jul 2.
7
Biotransformation of ginsenosides Re and Rg1 into ginsenosides Rg2 and Rh1 by recombinant β-glucosidase.重组β-葡萄糖苷酶转化人参皂苷 Re 和 Rg1 为人参皂苷 Rg2 和 Rh1。
Biotechnol Lett. 2012 May;34(5):913-7. doi: 10.1007/s10529-012-0849-z. Epub 2012 Jan 20.
8
Ginsenoside F1 production from ginsenoside Rg1 by a purified β-glucosidase from Fusarium moniliforme var. subglutinans.从亚粘帚霉中提取的β-葡萄糖苷酶对人参皂苷 Rg1 转化为人参皂苷 F1 的研究。
Biotechnol Lett. 2011 Dec;33(12):2457-61. doi: 10.1007/s10529-011-0719-0. Epub 2011 Aug 9.
9
Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo.人参皂苷代谢产物化合物K与γ射线辐射联合作用对人肺癌细胞的体内外效应
J Agric Food Chem. 2009 Jul 8;57(13):5777-82. doi: 10.1021/jf900331g.
10
Biotransformation of ginsenoside Rf to Rh1 by recombinant beta-glucosidase.重组β-葡萄糖苷酶将人参皂苷Rf转化为人参皂苷Rh1
Molecules. 2009 Jun 8;14(6):2043-8. doi: 10.3390/molecules14062043.